Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results
Go back to Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results| Genentech, Inc. (NYSE: DNA) | Delayed: 9.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.04 | 52 Week High | $99.14 | |||
| Open | $9.04 | 52 Week Low | $69.17 | |||
| Day High | $9.04 | P/E | 2.82 | |||
| Day Low | $9.04 | EPS | $3.21 | |||
| Volume | 11,870 | |||||

